These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


155 related items for PubMed ID: 26579965

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Cochlear implants in the management of hearing loss in Neurofibromatosis Type 2.
    Harris F, Tysome JR, Donnelly N, Durie-Gair J, Crundwell G, Tam YC, Knight RD, Vanat ZH, Folland N, Axon P.
    Cochlear Implants Int; 2017 May; 18(3):171-179. PubMed ID: 28335700
    [Abstract] [Full Text] [Related]

  • 23. Cochlear implantation in patients with neurofibromatosis type 2: variables affecting auditory performance.
    Carlson ML, Breen JT, Driscoll CL, Link MJ, Neff BA, Gifford RH, Beatty CW.
    Otol Neurotol; 2012 Jul; 33(5):853-62. PubMed ID: 22664900
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Bevacizumab for progressive vestibular schwannoma in neurofibromatosis type 2: a retrospective review of 31 patients.
    Plotkin SR, Merker VL, Halpin C, Jennings D, McKenna MJ, Harris GJ, Barker FG.
    Otol Neurotol; 2012 Aug; 33(6):1046-52. PubMed ID: 22805104
    [Abstract] [Full Text] [Related]

  • 30. Hearing preservation in neurofibromatosis type 2.
    Slattery WH, Brackmann DE, Hitselberger W.
    Am J Otol; 1998 Sep; 19(5):638-43. PubMed ID: 9752973
    [Abstract] [Full Text] [Related]

  • 31. Gamma Knife radiosurgery for vestibular schwannoma: clinical results at long-term follow-up in a series of 379 patients.
    Boari N, Bailo M, Gagliardi F, Franzin A, Gemma M, del Vecchio A, Bolognesi A, Picozzi P, Mortini P.
    J Neurosurg; 2014 Dec; 121 Suppl():123-42. PubMed ID: 25434946
    [Abstract] [Full Text] [Related]

  • 32. Microsurgery management of vestibular schwannomas in neurofibromatosis type 2: indications and results.
    Samii M, Gerganov V, Samii A.
    Prog Neurol Surg; 2008 Dec; 21():169-175. PubMed ID: 18810216
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Natural history of vestibular schwannomas and hearing loss in NF2 patients.
    Peyre M, Bernardeschi D, Sterkers O, Kalamarides M.
    Neurochirurgie; 2018 Nov; 64(5):342-347. PubMed ID: 26183546
    [Abstract] [Full Text] [Related]

  • 36. Hearing changes after diagnosis in neurofibromatosis type 2.
    Masuda A, Fisher LM, Oppenheimer ML, Iqbal Z, Slattery WH, Natural History Consortium.
    Otol Neurotol; 2004 Mar; 25(2):150-4. PubMed ID: 15021775
    [Abstract] [Full Text] [Related]

  • 37. Ipsilateral cochlear implantation in patients with sporadic vestibular schwannoma in the only or best hearing ear and in patients with NF2.
    Lassaletta L, Aristegui M, Medina M, Aranguez G, Pérez-Mora RM, Falcioni M, Gavilán J, Piazza P, Sanna M.
    Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):27-35. PubMed ID: 25537817
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Auditory brainstem implants for neurofibromatosis type 2.
    Colletti L, Shannon R, Colletti V.
    Curr Opin Otolaryngol Head Neck Surg; 2012 Oct; 20(5):353-7. PubMed ID: 22886036
    [Abstract] [Full Text] [Related]

  • 40. Outcome-based assessment of endolymphatic sac decompression for Ménière's disease using the Ménière's disease outcome questionnaire: a review of 90 patients.
    Convert C, Franco-Vidal V, Bebear JP, Darrouzet V.
    Otol Neurotol; 2006 Aug; 27(5):687-96. PubMed ID: 16868517
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.